Friday, June 01, 2012

Bristol, AstraZeneca among Amylin bidders-sources | Reuters


(Reuters) - AstraZeneca Plc (AZN.L) and Bristol-Myers Squibb Co (BMY.N) are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals Inc (AMLN.O), the diabetes drugmaker that is exploring a sale, according to people familiar with the matter.

Posted via email from Jack's posterous

No comments: